NCT00474825 - Dose Escalation Study of Hyperbaric Oxygen With Radiation and Chemotherapy to Treat Squamous Cell Carcinoma of the Head and Neck | Biotech Hunter

Enrollment

12

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

February 28, 2011

Study Completion Date

February 28, 2011

Conditions

Carcinoma, Squamous CellCancer of the Head and Neck

Interventions

DRUG

Hyperbaric Oxygen Therapy

Compression rate (breathing oxygen): per patient tolerance; 1 - 3 psi per minute Treatment dose: 2.4 ATA oxygen Treatment period: 30 minutes at 2.4 ATA Decompression rate (breathing oxygen): 2 - 3 psi per minute

DRUG

Hyperbaric Oxygen

Compression rate (breathing oxygen): per patient tolerance; 1 - 3 psi per minute Treatment dose: 2.4 ATA oxygen Treatment period: 30 minutes at 2.4 ATA Decompression rate (breathing oxygen): 2 - 3 psi per minute

DRUG

Hyperbaric oxygen

Compression rate (breathing oxygen): per patient tolerance; 1 - 3 psi per minute Treatment dose: 2.4 ATA oxygen Treatment period: 30 minutes at 2.4 ATA Decompression rate (breathing oxygen): 2 - 3 psi per minute

DRUG

Hyperbaric oxygen

Compression rate (breathing oxygen): per patient tolerance; 1 - 3 psi per minute Treatment dose: 2.4 ATA oxygen Treatment period: 30 minutes at 2.4 ATA Decompression rate (breathing oxygen): 2 - 3 psi per minute

Trial Locations (3)

23507

Norfolk General Hospital / Eastern Virginia Medical School, Norfolk

55905

The Mayo Clinic, Rochester

03756

Dartmouth-Hitchcock Medical Center, Lebanon